For informational and research purposes only. Not medical advice. Content is aggregated from public sources. Always consult a qualified healthcare provider.
Anti-Aging & Longevity · Comparison

Carnosine vs SS-31

A neutral, side-by-side comparison of two anti-aging & longevity peptides — their mechanisms, dosing ranges, administration routes, side effects, and research evidence. For research and educational purposes only.

CarnosineSS-31
CategoryAnti-Aging & LongevityAnti-Aging & Longevity
Also known asβ-alanyl-L-histidine, L-carnosine, brain dipeptide, muscle dipeptideElamipretide, MTP-131, Bendavia, Szeto-Schiller peptide 31
EvidenceResearch-stageInvestigational (in trials)
Dosing range500mg–2000mg mg, twice daily oral1mg–10mg mg, daily or every other day
AdministrationOral (capsule/powder), Topical (eye drops — cataract research)Subcutaneous injection, Intravenous (clinical trials)
Key side effectsGenerally well-tolerated, Mild GI discomfort at high doses (>2g/day), Rare: carnosinemia in carnosinase deficiency (genetic condition), Zinc chelation may reduce zinc availability at very high dosesInjection site reactions, Nausea (rare), Generally well-tolerated in clinical trial populations
Cited sources2 references2 references

Key differences

  • Evidence level differs: Carnosine is research-stage, while SS-31 is investigational (in trials).
  • Administration: Carnosine — Oral (capsule/powder), Topical (eye drops — cataract research); SS-31 — Subcutaneous injection, Intravenous (clinical trials).
  • Frequency: Carnosine is typically twice daily oral; SS-31 is daily or every other day.

How each works

Carnosine

Carnosine's multi-mechanism activity explains interest across several research domains. Its histidine moiety buffers intramuscular pH during high-intensity exercise, directly improving performance. As an anti-glycation agent, carnosine quenches reactive carbonyl species that form advanced glycation end-products (AGEs), potentially slowing protein crosslinking associated with tissue aging. Brain carnosine concentrations correlate with cognitive vitality in aging research.

SS-31

SS-31 selectively accumulates in mitochondria and binds cardiolipin — a phospholipid critical for the electron transport chain. By stabilizing cardiolipin, SS-31 restores ATP production, reduces reactive oxygen species (ROS), and prevents mitochondrial permeability transition. Animal studies show dramatic reversal of mitochondrial dysfunction in aged tissues.

Read the full Carnosine profileRead the full SS-31 profile

This comparison aggregates public research and structured profile data for informational purposes only. It is not medical advice and does not recommend either compound for human use. Consult a qualified healthcare provider before considering any peptide.